January 14, 2022

Ascendia Pharmaceuticals Participates in Virtual Nasdaq Opening Bell Ceremony Celebrating J.P. Morgan Healthcare Conference

READ MORE
October 27, 2021
Biologics vs. Small Molecule Drugs: Which Are Better?
October 12, 2021
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
October 7, 2021
Ascendia to Highlight CDMO Services at AAPS PharmSci360
September 13, 2021
Development and Scale Up Considerations for Nanosuspension Dosage Forms
August 20, 2021
How to Successfully Utilize ASDs for Drug Delivery of Insoluble Drugs
August 11, 2021
Top Considerations When Developing Formulations for Injectable Solutions
August 3, 2021
Considerations in Development and Manufacturing of Complex Injectables for Early Phase Studies
August 2, 2021
Top CDMO Companies: Why Bigger Isn’t Always Better
July 26, 2021
5 Novel Techniques for Solubility Enhancement

Want to learn more about
Ascendia's expertise?

Get up-to-date information

Stay in touch >